Platform methods and custom assay development

Developers of ATMPs face unique challenges intended to demonstrate compilance with quality and regulatory requirements that address patients safety.

At Eurofins BioPharma Product Testing Italy, we advocate to deliver our sophisticated expertise, to support clients to tackle these critical challenges during the ATMP development journey. Within this scope we have implemented a dedicated Cell and Gene therapies (CGTs) team to develop new platform methods and innovative approaches able to solve unique problems. Multiple platform methods are now available that can be customised depending on client's specific needs.

This underscores our dedication to stay at the forefront of the global scientific innovation as we continue to offer groundbreaking services to ATMPs developers.

Our multidisciplinary team is daily involved in set-up, development, and optimization of analytical methods. Our scientists and Subject Matter Experts will support you in designing the most appropriate assay. No matter whether you are developing a new assay or reworking an existing one, we can provide the best solution to ensure that your project will be successful.

Do you have a project in mind? Contact us.